128 related articles for article (PubMed ID: 8306203)
1. Effect of temperature on glyceryl trinitrate induced relaxation of rabbit aorta.
Booth BP; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1993 Aug; 71(8):629-32. PubMed ID: 8306203
[TBL] [Abstract][Full Text] [Related]
2. Biotransformation of glyceryl trinitrate occurs concurrently with relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Breedon TH; Bennett BM; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1986 May; 237(2):608-14. PubMed ID: 3084761
[TBL] [Abstract][Full Text] [Related]
3. Biotransformation of glyceryl trinitrate and elevation of cyclic GMP precede glyceryl trinitrate-induced vasodilation.
Kawamoto JH; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
J Cardiovasc Pharmacol; 1990 May; 15(5):714-9. PubMed ID: 1692930
[TBL] [Abstract][Full Text] [Related]
4. Vascular and anti-platelet actions of 1,2- and 1,3-glyceryl dinitrate.
Salvemini D; Pistelli A; Anggard E
Br J Pharmacol; 1993 Nov; 110(3):937-42. PubMed ID: 8298817
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of glyceryl trinitrate-induced vasodilation. I. Relationship between drug biotransformation, tissue cyclic GMP elevation and relaxation of rabbit aorta.
Brien JF; McLaughlin BE; Kobus SM; Kawamoto JH; Nakatsu K; Marks GS
J Pharmacol Exp Ther; 1988 Jan; 244(1):322-7. PubMed ID: 2826771
[TBL] [Abstract][Full Text] [Related]
6. The role of nitric oxide formation in organic nitrate-induced vasodilation and organic nitrate tolerance.
Marks GS; Nakatsu K; McLaughlin B; Kawamoto J; Slack C; Brien JF
Z Kardiol; 1989; 78 Suppl 2():18-21; discussion 64-7. PubMed ID: 2555978
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide formation from glyceryl trinitrate by rabbit aortic strip: detection by rabbit taenia coli concurrent with vasorelaxation.
Hussain AS; Poklewska-Koziell M; Brien JF; Marks GS; Nakatsu K
Br J Pharmacol; 1994 Dec; 113(4):1508-14. PubMed ID: 7889309
[TBL] [Abstract][Full Text] [Related]
8. Lack of evidence for the involvement of cytochrome P-450 or other hemoproteins in metabolic activation of glyceryl trinitrate in rabbit aorta.
Liu Z; Brien JF; Marks GS; McLaughlin BE; Nakatsu K
J Pharmacol Exp Ther; 1993 Mar; 264(3):1432-9. PubMed ID: 8450477
[TBL] [Abstract][Full Text] [Related]
9. Carbon monoxide does not inhibit glyceryl trinitrate biotransformation by or relaxation of aorta.
Liu Z; Brien JF; Marks GS; McLaughlin BE; Nakatsu K
Eur J Pharmacol; 1992 Jan; 211(1):129-32. PubMed ID: 1618261
[TBL] [Abstract][Full Text] [Related]
10. Differential biotransformation of glyceryl trinitrate by red blood cell-supernatant fraction and pulmonary vein homogenate.
Marks GS; McLaughlin BE; MacMillan HF; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1989 May; 67(5):417-22. PubMed ID: 2504466
[TBL] [Abstract][Full Text] [Related]
11. Effects of sulfobromophthalein and ethacrynic acid on glyceryl trinitrate relaxation.
Lau DT; Benet LZ
Biochem Pharmacol; 1992 May; 43(10):2247-54. PubMed ID: 1599510
[TBL] [Abstract][Full Text] [Related]
12. Tissue disposition of glyceryl trinitrate, 1,2-glyceryl dinitrate, and 1,3-glyceryl dinitrate in tolerant and nontolerant rats.
Torfgård KE; Ahlner J; Axelsson KL; Norlander B; Bertler A
Drug Metab Dispos; 1992; 20(4):553-8. PubMed ID: 1356734
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide-induced vasodilation of organic nitrate-tolerant rabbit aorta.
Slack CJ; McLaughlin BE; Nakatsu K; Marks GS; Brien JF
Can J Physiol Pharmacol; 1988 Oct; 66(10):1344-6. PubMed ID: 3149205
[TBL] [Abstract][Full Text] [Related]
14. Biotransformation of glyceryl trinitrate and isosorbide dinitrate in vascular smooth muscle made tolerant to organic nitrates.
Slack CJ; McLaughlin BE; Brien JF; Marks GS; Nakatsu K
Can J Physiol Pharmacol; 1989 Nov; 67(11):1381-5. PubMed ID: 2516767
[TBL] [Abstract][Full Text] [Related]
15. Different effects of ascorbate deprivation and classical vascular nitrate tolerance on aldehyde dehydrogenase-catalysed bioactivation of nitroglycerin.
Wenzl MV; Wölkart G; Stessel H; Beretta M; Schmidt K; Mayer B
Br J Pharmacol; 2009 Apr; 156(8):1248-55. PubMed ID: 19254277
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of the biotransformation and pharmacological actions of glyceryl trinitrate by the flavoprotein inhibitor, diphenyleneiodonium sulfate.
McGuire JJ; Anderson DJ; Bennett BM
J Pharmacol Exp Ther; 1994 Nov; 271(2):708-14. PubMed ID: 7965786
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of glyceryl trinitrate by rat brain homogenate.
Marks GS; McLaughlin BE; Nakatsu K; Brien JF
Can J Physiol Pharmacol; 1992 Jun; 70(6):935-7. PubMed ID: 1423038
[TBL] [Abstract][Full Text] [Related]
18. Conversion of glyceryl trinitrate to nitric oxide in tolerant and non-tolerant smooth muscle and endothelial cells.
Salvemini D; Pistelli A; Vane J
Br J Pharmacol; 1993 Jan; 108(1):162-9. PubMed ID: 8381319
[TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics and pharmacodynamics of glyceryl trinitrate and its metabolites.
Hashimoto S; Kobayashi A
Clin Pharmacokinet; 2003; 42(3):205-21. PubMed ID: 12603173
[TBL] [Abstract][Full Text] [Related]
20. The effects of hypothermic and normothermic cardiopulmonary bypass on glyceryl trinitrate activity.
Booth BP; Brien JF; Marks GS; Milne B; Cervenko F; Pym J; Knight J; Rogers K; Salerno T; Nakatsu K
Anesth Analg; 1994 May; 78(5):848-56. PubMed ID: 8160981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
